2018
DOI: 10.3389/fcvm.2018.00128
|View full text |Cite
|
Sign up to set email alerts
|

Response Gene to Complement 32 in Vascular Diseases

Abstract: Response gene to complement 32 (RGC32) is a protein that was identified in rat oligodendrocytes after complement activation. It is expressed in most of the organs and tissues, such as brain, placenta, heart, and the liver. Functionally, RGC32 is involved in various physiological and pathological processes, including cell proliferation, differentiation, fibrosis, metabolic disease, and cancer. Emerging evidences support the roles of RGC32 in vascular diseases. RGC32 promotes injury-induced vascular neointima fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 32 publications
0
8
0
Order By: Relevance
“…S19). Dysregulation of genes encoding factors involved in EC fate, blood vessel development, and angiogenesis (NOTCH4, FLT1, FGFR1, and RGCC) (42)(43)(44) in disease LVs indicated that vascular remodeling was a common heart failure feature.…”
Section: Endothelial Cellsmentioning
confidence: 99%
“…S19). Dysregulation of genes encoding factors involved in EC fate, blood vessel development, and angiogenesis (NOTCH4, FLT1, FGFR1, and RGCC) (42)(43)(44) in disease LVs indicated that vascular remodeling was a common heart failure feature.…”
Section: Endothelial Cellsmentioning
confidence: 99%
“…We identified an epitope with a relatively large sequence (39AA) with homology to response gene to complement 32 (RGC32). RGC32 is induced by p53 in response to DNA damage and expressed in various tissues and is involved in numerous physiological and pathological processes, including cell proliferation, differentiation, fibrosis, metabolic disease [ 65 ]. The corresponding gene is involved in aniogenesis and regulated through hypoxia response element [ 66 ].…”
Section: Discussionmentioning
confidence: 99%
“…Due to its roles in modulating cell cycle progression that were discovered in the past decades, it was renamed as regulator of cell cycle ( RGCC ) (Counts & Mufson, 2017). RGCC has been reported to regulate multiple cellular processes in various tissues such as kidney (Guo et al , 2011; Li et al , 2011), liver and adipose tissue (Cui et al , 2015), nervous system (Counts & Mufson, 2017; Kim & Park, 2019; Vlaicu et al , 2019), smooth muscle, and heart (Vlaicu et al , 2016) and has been implicated in many pathologic conditions, including cardiovascular (Cui & Chen, 2018), metabolic (Cui et al , 2015), renal (Li et al , 2011; Niu et al , 2011), autoimmune (Sun & Chen, 2018; Kim & Park, 2019), and neurodegenerative diseases (Counts & Mufson, 2017), as well as several cancers (Fosbrink et al , 2005; Vlaicu et al , 2010; Zhu et al , 2012; Sun et al , 2013; Xu et al , 2014). However, the roles of RGCC vary in different tissues and pathological processes.…”
Section: Discussionmentioning
confidence: 99%